There's a crop of great biotech companies ready to be acquired, says MPM's Christiana Bardon

Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the pharmaceutical and biotech sector, innovation in obesity drugs, and acquisition risk in pharmaceuticals.